State Street’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

State Street’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-112,859	Closed	-$554K	–	4850
2021 Q3	$554K	Buy	112,859 +9,700	+9%	+$47.6K	﹤0.01%	3934
2021 Q2	$545K	Buy	103,159 +86,976	+537%	+$460K	﹤0.01%	3827
2021 Q1	$78K	Buy	16,183 +1,600	+11%	+$7.71K	﹤0.01%	3918
2020 Q4	$63K	Hold	14,583	–	–	﹤0.01%	3836
2020 Q3	$60K	Sell	14,583 -35,300	-71%	-$145K	﹤0.01%	3743
2020 Q2	$128K	Sell	49,883 -392,626	-89%	-$1.01M	﹤0.01%	3644
2020 Q1	$1.28M	Buy	442,509 +23,005	+5%	+$66.5K	﹤0.01%	3246
2019 Q4	$1.59M	Buy	419,504 +1,980	+0.5%	+$7.51K	﹤0.01%	3315
2019 Q3	$2.14M	Buy	417,524 +9,613	+2%	+$49.2K	﹤0.01%	3192
2019 Q2	$2.53M	Buy	407,911 +18,171	+5%	+$113K	﹤0.01%	3151
2019 Q1	$2.77M	Sell	389,740 -3,553	-0.9%	-$25.3K	﹤0.01%	3031
2018 Q4	$3.36M	Sell	393,293 -1,443,599	-79%	-$12.3M	﹤0.01%	2902
2018 Q3	$36.8M	Sell	1,836,892 -354,900	-16%	-$7.1M	﹤0.01%	1757
2018 Q2	$56.6M	Sell	2,191,792 -611,315	-22%	-$15.8M	﹤0.01%	1400
2018 Q1	$67M	Buy	2,803,107 +1,439,606	+106%	+$34.4M	0.01%	1245
2017 Q4	$46.2M	Buy	1,363,501 +1,103,027	+423%	+$37.4M	﹤0.01%	1470
2017 Q3	$5.51M	Sell	260,474 -24,885	-9%	-$527K	﹤0.01%	2760
2017 Q2	$4.99M	Buy	285,359 +23,708	+9%	+$415K	﹤0.01%	2730
2017 Q1	$4.58M	Buy	261,651 +3,966	+2%	+$69.5K	﹤0.01%	2743
2016 Q4	$4.36M	Buy	257,685 +15,216	+6%	+$257K	﹤0.01%	2765
2016 Q3	$3.98M	Buy	242,469 +17,754	+8%	+$291K	﹤0.01%	2691
2016 Q2	$3.4M	Buy	224,715 +53,956	+32%	+$817K	﹤0.01%	2831
2016 Q1	$2.47M	Buy	170,759 +11,002	+7%	+$159K	﹤0.01%	2913
2015 Q4	$4.52M	Buy	159,757 +21,270	+15%	+$602K	﹤0.01%	2585
2015 Q3	$2.32M	Buy	138,487 +49,047	+55%	+$821K	﹤0.01%	2937
2015 Q2	$2.35M	Buy	89,440 +59,133	+195%	+$1.55M	﹤0.01%	2999
2015 Q1	$529K	Buy	30,307 +6,609	+28%	+$115K	﹤0.01%	3358
2014 Q4	$410K	Buy	23,698 +961	+4%	+$16.6K	﹤0.01%	3425
2014 Q3	$424K	Buy	+22,737	New	+$424K	﹤0.01%	3397